Current stock page

Stock Analysis

Verastem, Inc. (VSTM) Stock Analysis

Verastem, Inc. (VSTM) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

VSTM Stock Analysis Summary

Verastem, Inc. (VSTM) currently has an AIQ Score of 60/100, indicating a neutral setup. Momentum is the strongest factor at 89/100. Risk is the weakest current factor at 36/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

VSTM at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$8.18
AIQ Score60/100
Overall ViewNeutral
Technical Analysis ConsensusSell
Market Cap$828.11M
P/E Ratio (TTM)-4.42
Forward P/E—
EPS (Q3 FY2026)-$0.74
Revenue (Q3 FY2026)$24.01M
Dividend Yield (TTM)0.00%
Beta0.89
Volume1.72M
52-week range$3.43-$10.82
RSI 1441.63
50-Day SMA$8.49
200-Day SMA$6.30
Analyst Price Target$18.50
Next EarningsMar 3, 2027
As of Nov 13, 2026 · Market close

VSTMVerastem, Inc.

Healthcare / Biotechnology

Low Priority

Above Peers

NeutralEdge 6/10
$8.18−$0.26 (−3.08%)

Latest quote

  • Momentum
    89
  • Value
    53
  • Quality
    42
  • Risk resilience
    36
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

VSTM Stock Analysis Summary

Verastem, Inc. (VSTM) currently has an AIQ Score of 60/100, indicating a neutral setup. Momentum is the strongest factor at 89/100. Risk resilience is the weakest current factor at 36/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Neutral

In a neutral regime, VSTM has AIQ Score of 60/100 with Momentum base of 89/100 and fading Risk resilience at 36/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (89/100) leads while Risk resilience (36/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · -3.08% stock move · VSTM classified in Biotechnology.

Current Evidence

NeutralVSTM is in a neutral AIQ regime; Momentum is the strongest visible factor at 89/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is VSTM Bullish or Bearish Right Now?

VSTM currently has a neutral overall setup. Momentum is the strongest factor at 89/100, while Risk Resilience is weakest at 36/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.

Bull Case
  • - Momentum is constructive at 89/100.
  • - Analyst target implies +126.16% upside from the latest quote.
Bear Case
  • - Risk Resilience is weak at 36/100.
  • - Technical consensus has more sell votes than buy votes (28 vs 14).

Current Consensus

VSTM's Technical Analysis Consensus is currently Sell, with 14 buy, 4 neutral, and 28 sell votes. VSTM's 14-day RSI is 41.63, which places the stock in a weaker momentum range. VSTM's beta is 0.89, indicating market sensitivity broadly in line with the market.

Signal Confidence
High agreement

What Changed in VSTM?

The largest recent change in VSTM is Momentum moving down by 1.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
+0.0
Momentum
-1.0
Quality
+0.0
Risk
+0.0

What Would Change the VSTM Outlook?

The current neutral outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

VSTM Decision Framework

Public evidence layers, setup checks, and risk context for Verastem, Inc..

Verastem, Inc. (VSTM) Stock Analysis

Verastem, Inc. has an AIQ Score of 60/100 in a Neutral regime. Momentum is strongest at 89/100. Beta is 0.89, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextVSTM is in a Neutral AIQ regime with score 60/100.
Signal ConflictThe primary conflict is that momentum leads at 89/100 while risk lags at 36/100.
Factor EvidenceMomentum 89/100 · Value 53/100 · Quality 42/100 · Risk 36/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Momentum is the strongest factor at 89/100.

TimingPass

Momentum is 89/100 and RSI (14) is 41.6.

Regime fitWait

VSTM is in a Neutral regime at 60/100.

Risk controlFail

Risk factor is 36/100 with beta 0.89 and annual volatility 74.24%.

ConflictWait

Current conflict: momentum leads at 89/100 while risk lags at 36/100.

AIQ Score
60/100
Price
$8.18
Beta
0.89
RSI (14)
41.6

VSTM Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

VSTM Fundamentals

VSTM valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$24.01M
Net income
-$74.72M
Free cash flow
-$33.59M
View full VSTM fundamental analysis

VSTM Technical Analysis

VSTM technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Sell
RSI 14
41.63
Price vs SMA-50
-3.60%
View full VSTM technical analysis

VSTM Stock Catalysts

Track VSTM earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Mar 3, 2027
Analyst target
$18.50
News items
5
View VSTM earnings and stock catalysts

VSTM Dividend Analysis

VSTM dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View VSTM dividend history and analysis

VSTM Financial Data

VSTM revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$24.01M
EPS
-$0.74
Periods
8
View VSTM financials

VSTM Risk Analysis

VSTM volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.89
Risk score
36/100
1Y volatility
74.24%
View VSTM risk analysis

VSTM Stock News

VSTM stock news, market tone, recent headlines, and catalyst context.

News items
5
Updated
Nov 15, 2026
Sentiment
—
Read VSTM stock news

VSTM vs Biotechnology Peers

Current peer cohort: VSTM · XENE · XERS · ZBIO · ZYME. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
VSTM
Current stock
60/10053/10089/10036/1000.3274.24%Current
XENE
Xenon Pharmaceuticals Inc.
49/100—33/10049/1000.2768.13%VSTM vs XENE
XERS
Xeris Biopharma Holdings, Inc.
78/10068/10098/10055/1001.6756.97%VSTM vs XERS
ZBIO
Zenas BioPharma, Inc.
47/10033/10078/10039/1000.2695.33%VSTM vs ZBIO
ZYME
Zymeworks Inc.
68/10066/10078/10061/1000.8454.03%VSTM vs ZYME
Pairwise Compare links: XENE · XERS · ZBIO · ZYMEVSTM vs XENEVSTM vs XERSVSTM vs ZBIOVSTM vs ZYMECompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a VSTM stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for VSTM: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-4.42
As of Nov 13, 2026
Revenue growth
113.59%
Gross margin
86.11%
Current debt / equity
12.09
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$24.01M
Quarter net income
-$74.72M
Quarter free cash flow
-$33.59M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Mixed
Momentum
Bearish
RSI 14
41.63
MACD
0.02

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
36/100
Beta
0.89
Annual volatility
74.24%
Max drawdown
-67.58%

VSTM Stock FAQ

What is VSTM stock price today?

Verastem, Inc.'s current stock price is $8.18. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is VSTM bullish or bearish right now?

VSTM's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is VSTM's market cap?

VSTM's market cap is $828.11M based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is VSTM's current P/E ratio?

VSTM's current P/E ratio is -4.42 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is VSTM's RSI?

VSTM's 14-day RSI is 41.63 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is VSTM above its 50-day and 200-day moving averages?

VSTM is -3.60% from its 50-day SMA and 29.92% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is VSTM's next earnings date?

VSTM's next earnings date is currently listed as Mar 3, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does VSTM pay a dividend?

VSTM's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.